Psychedelics for the Treatment of Obesity: Review of The Evidence and a Call to Action (Recorded Webinar)

As psychedelics become increasingly decriminalized in various cities and countries, and excitement builds among scientists, physicians, and the general public, it is likely that more individuals with obesity will seek out these emerging treatments. For researchers and clinicians in obesity medicine, it is essential to stay informed about the latest developments in psychedelic therapies and their potential applications in obesity care. This session will provide a balanced, evidence-based overview of the current research on psychedelics, equipping participants with the knowledge to assess their potential role in obesity treatment.

CME/CE Expiration Date: 11/5/27

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

You may also be interested in

CBD for Obesity? Our Patients are Asking! A Review of the Current Science (Recorded)

Our patients frequently ask if they should take CBD to assist with weight loss.
Obesity Medicine 2024 - Beyond Medication: The Role of Behavior Change (Recorded)

Incretin medications, like semaglutide and tirzepatide, suppress appetite and delay gastric emptying, facilitating weight loss and begging the question of the need for concurrent behavior change therapy.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.
Course opens: 
11/05/2024
Course expires: 
11/05/2027
Cost:
$25.00

Erin Mauney, MD

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.

Price

Cost:
$25.00
Please login or register to take this course.

Required Hardware/software

For best user experience we recommend using a computer to complete this course.